BGI achieves next-gen sequencing analysis of FFPE DNA as low as 200 ng

BGI, the world's largest genomics organization, reported that it can use next-generation sequencing to analyze DNA as low as 200 ng from formalin-fixed paraffin-embedded (FFPE) samples. This advancement enables researchers to easily identify the genetic details and pathology mechanism of FFPE disease samples, especially for some rare tumors, with higher accuracy and reliability than existing techniques.

FFPE samples are common for disease diagnoses and scientific research. Because FFPE tissue samples may be stored indefinitely at room temperature, and (both DNA and RNA) may be recovered after decades from the original fixation, they have become an important resource for historical studies in medicine. There are millions of FFPE samples stored worldwide containing significant genetic information for disease and medical research.

With the rapid development of genomics, the ability to sequence FFPE samples opens up large tissue collections from clinical trials for genetic analysis that could help researchers identify novel variations that are linked to disease development. However, during the sample preparation and storage process, formaldehyde can induce modification of nucleotide molecules, such as , DNA-protein cross-links (DPC), among others. This hampers further application and development of sequencing in exploring the of diseases.

Recently, BGI researchers have made a breakthrough on FFPE DNA sequencing by achieving optimization of FFPE construction with total DNA degraded to as low as 200 ng. "This is a critical step toward better decoding the potential genetic information of FFPE samples," said Xun Zhao, staff scientist from BGI Department of DNA Sequencing. "In order to fully understand the heterogeneity and special properties of FFPE samples, we hope to conduct more FFPE DNA sequencing projects with collaborators worldwide to further enhance and standardize our technique."

"We expect that next-generation sequencing technologies with FFPE samples could substantially facilitate our understanding of undefined pathological mechanisms and broaden our insights in biomedical research," added Zhao. "This also strengthens the confidence of researchers in pharmaceutical and disease areas, especially when samples are limited."

add to favorites email to friend print save as pdf

Related Stories

Single-cell sequencing leads to a new era of cancer research

Mar 02, 2012

BGI, the world's largest genomics organization, developed single-cell genome sequencing technology and published two research papers for cancer single-cell sequencing in the research journal Cell. In the papers, which were p ...

Researchers find extensive RNA editing in human transcriptome

Feb 12, 2012

In a new study published online in Nature Biotechnology, researchers from BGI, the world's largest genomics organization, reported the evidence of extensive RNA editing in a human cell line by analysis of RNA-seq data, demons ...

Recommended for you

Infant failure to thrive linked to lysosome dysfunction

8 hours ago

Neonatal intestinal disorders that prevent infants from getting the nutrients they need may be caused by defects in the lysosomal system that occur before weaning, according to a new Northwestern Medicine ...

Gene may open door for improved keloid, scar treatment

Jan 23, 2015

Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.